Skip to main content
S 3733 118th Congress Senate Health Administrative law and regulatory procedures Civil actions and liability Congressional oversight Department of Health and Human Services Health programs administration and funding Health promotion and preventive care Organ and tissue donation and transplantation

Shandra Eisenga Human Cell and Tissue Product Safety Act

Introduced: February 5, 2024 Introduced by: Peters, Gary C. Democratic · Michigan See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 5, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 5, 2024
Introduced in Senate
 Plain-English summary Congressional Research Service

Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that use human cell or tissue products, including the risk of infections.

HHS must develop the educational campaign after taking into consideration information about products that carry the highest risk of transmitting infections to transplant recipients. HHS may award grants to other entities to conduct public awareness initiatives and media campaigns about the risk of infections. 

The bill also establishes specific civil penalties for violations of laws regarding the spread of communicable diseases and regulations regarding procedures for human cell or tissue products.

What's happening now February 5, 2024

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1